Paola Finsinger

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapy.

Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapy.

Journal: Blood reviews

Published: January 28, 2025

Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study).

Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study).

Journal: Leukemia research reports

Published: October 24, 2023

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.

Journal: Hematological oncology

Published: May 26, 2023

Assessing eligibility for treatment in acute myeloid leukemia in 2023.

Assessing eligibility for treatment in acute myeloid leukemia in 2023.

Journal: Expert review of hematology

Published: March 06, 2023

Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience.

Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience.

Journal: Hematological oncology

Published: October 28, 2022

Bendamustine and dexamethasone are an effective salvage regimen for patients with advanced multiple myeloma in a Home Care Unit program.

Bendamustine and dexamethasone are an effective salvage regimen for patients with advanced multiple myeloma in a Home Care Unit program.

Journal: Leukemia & lymphoma

Published: December 24, 2015

An observational study assessing peripheral neuropathy related to multiple myeloma.

An observational study assessing peripheral neuropathy related to multiple myeloma.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: November 16, 2015

Clinical features and prognostic factors in solitary plasmacytoma.

Clinical features and prognostic factors in solitary plasmacytoma.

Journal: British journal of haematology

Published: August 21, 2015

Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?

Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?

Journal: Hematological oncology

Published: May 08, 2015

Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib.

Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib.

Journal: American journal of hematology

Published: September 17, 2014

Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits.

Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits.

Journal: Patient preference and adherence

Published: July 22, 2014

Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.

Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.

Journal: Annals of hematology

Published: April 14, 2014

Showing 1-12 of 22

Last Updated: 09/26/2026